12 research outputs found
Impaired SARS-CoV-2 specific T-cell response in patients with severe COVID-19
Cellular immune responses are of pivotal importance to understand SARS-CoV-2 pathogenicity. Using an enzyme-linked immunosorbent spot (ELISpot) interferon-γ release assay with wild-type spike, membrane and nucleocapsid peptide pools, we longitudinally characterized functional SARS-CoV-2 specific T-cell responses in a cohort of patients with mild, moderate and severe COVID-19. All patients were included before emergence of the Omicron (B.1.1.529) variant. Our most important finding was an impaired development of early IFN-γ-secreting virus-specific T-cells in severe patients compared to patients with moderate disease, indicating that absence of virus-specific cellular responses in the acute phase may act as a prognostic factor for severe disease. Remarkably, in addition to reactivity against the spike protein, a substantial proportion of the SARS-CoV-2 specific T-cell response was directed against the conserved membrane protein. This may be relevant for diagnostics and vaccine design, especially considering new variants with heavily mutated spike proteins. Our data further strengthen the hypothesis that dysregulated adaptive immunity plays a central role in COVID-19 immunopathogenesis
Chronic Q fever diagnosis—consensus guideline versus expert opinion
Chronic Q fever, caused by Coxiella burnetii, has high mortality and morbidity rates if left untreated. Controversy about the diagnosis of this complex disease has emerged recently. We applied the guideline from the Dutch Q FeÂver Consensus Group and a set of diagnostic criteria proÂposed by Didier Raoult to all 284 chronic Q fever patients included in the Dutch National Chronic Q Fever Database during 2006–2012. Of the patients who had proven casÂes of chronic Q fever by the Dutch guideline, 46 (30.5%) would not have received a diagnosis by the alternative criÂteria designed by Raoult, and 14 (4.9%) would have been considered to have possible chronic Q fever. Six patients with proven chronic Q fever died of related causes. Until results from future studies are available, by which current guidelines can be modified, we believe that the Dutch litÂerature-based consensus guideline is more sensitive and easier to use in clinical practice
Differential abundance of IgG antibodies against the spike protein of SARS-CoV-2 and seasonal coronaviruses in patients with fatal COVID-19
Abstract Infection with the novel pandemic SARS-CoV-2 virus has been shown to elicit a cross-reactive immune response that could lead to a back-boost of memory recall to previously encountered seasonal (endemic) coronaviruses (eCoVs). Whether this response is associated with a fatal clinical outcome in patients with severe COVID-19 remains unclear. In a cohort of hospitalized patients, we have previously shown that heterologous immune responses to eCoVs can be detected in severe COVID-19. Here, we report that COVID-19 patients with fatal disease have decreased SARS-CoV-2 neutralizing antibody titers at hospital admission, which correlated with lower SARS-CoV-2 spike-specific IgG and was paralleled by a relative abundance of IgG against spike protein of eCoVs of the genus Betacoronavirus. Additional research is needed to assess if eCoV-specific back-boosted IgG is a bystander phenomenon in severe COVID-19, or a factor that influences the development of an efficient anti-viral immune response
Characteristics of chronic Q fever patients and control individuals.
<p>n.a., not applicable.</p>a<p>At the time of bloodsampling.</p
ROC curves of the IFN-γ production assay and the <i>Coxiella</i> ELISPOT. ROC curves are shown for each assay with each stimulating antigen separately.
<p>Abbreviations: NMI, Nine Mile phase 1; NMII, Nine Mile phase 2; IFN-γ, interferon-gamma.</p
Correlation between the amount of <i>C. burnetii</i>-specific IFN-γ production and the number of IFN-γ positive cells.
<p>The individual values of chronic Q fever patients (n = 16) were used to determine the correlation between the IFN-γ production as measured with the IFN-γ production assay, and the number of IFN-γ positive cells as measured with the <i>Coxiella</i> ELISPOT. Each graph shows the correlation between the resulting values of the two assays, with either one of the stimulating antigens. On the Y-axes, the IFN-γ production is shown after stimulation with NMI (upper graphs) and Henzerling antigens (lower graphs). On the X-axes, the spot count is shown after stimulation with NMI (left graphs) and NMII (right graphs) antigens. The Spearman’s correlation coefficient <i>r</i> (95% Confidence Interval) is given for each comparison. Abbreviations: NMI, Nine Mile phase 1; NMII, Nine Mile phase 2; IFN-γ, interferon-gamma.</p
Results of the IFN-γ production assay and <i>Coxiella</i> ELISPOT in chronic Q fever patients and control subjects.
<p><i>In vitro</i> IFN-γ production by whole blood in response to Henzerling and Nine Mile phase 1 antigens was measured in the IFN-γ production assay. The number of IFN-γ positive cells in response to Nine Mile phase 1 and Nine Mile phase 2 antigens was measured in the <i>Coxiella</i> ELISPOT. Individual values of patients and controls are shown separately, and the lines indicate the medians. Patients and controls were compared using the Mann-Whitney <i>U</i>-test. ***<i>P</i><0.001, **<i>P</i><0.01. Abbreviations: NMI, Nine Mile phase 1; NMII, Nine Mile phase 2; IFN-γ, interferon-gamma.</p
DataSheet_1_Impaired SARS-CoV-2 specific T-cell response in patients with severe COVID-19.docx
Cellular immune responses are of pivotal importance to understand SARS-CoV-2 pathogenicity. Using an enzyme-linked immunosorbent spot (ELISpot) interferon-γ release assay with wild-type spike, membrane and nucleocapsid peptide pools, we longitudinally characterized functional SARS-CoV-2 specific T-cell responses in a cohort of patients with mild, moderate and severe COVID-19. All patients were included before emergence of the Omicron (B.1.1.529) variant. Our most important finding was an impaired development of early IFN-γ-secreting virus-specific T-cells in severe patients compared to patients with moderate disease, indicating that absence of virus-specific cellular responses in the acute phase may act as a prognostic factor for severe disease. Remarkably, in addition to reactivity against the spike protein, a substantial proportion of the SARS-CoV-2 specific T-cell response was directed against the conserved membrane protein. This may be relevant for diagnostics and vaccine design, especially considering new variants with heavily mutated spike proteins. Our data further strengthen the hypothesis that dysregulated adaptive immunity plays a central role in COVID-19 immunopathogenesis.</p